Sonova (SOON) Investor Presentation summary
Event summary combining transcript, slides, and related documents.
Investor Presentation summary
27 Jun, 2025Market position and industry dynamics
Holds a leading position in the hearing industry with a vertically integrated business model and global distribution network.
Attractive secular growth drivers include significant penetration potential in mild/moderate hearing loss and high-growth developing markets.
Focuses on sustainability with industry-leading ESG performance and ambitious climate actions.
Maintains strong financials, including attractive profit margins, strong balance sheet, and capacity for growth investments.
Product and service innovation
Offers a broad portfolio: audiological care, hearing instruments (RIC, ITE, BTE), wireless systems, consumer headphones, and cochlear implants.
Leads in innovation with real-time AI-based sound processing, dual-chip architecture, and advanced connectivity.
New Infinio and Sphere Infinio platforms deliver up to 50% more access to speech cues and reduce listening effort by 45%.
Over 340,000 units sold from new platforms in five months, with strong market share gains in premium categories.
Strategic growth and execution
Strategy centers on innovation, expanding consumer access, omni-channel care, and M&A to accelerate growth.
Targets mid-term sales CAGR of 6–9% and adj. EBITA CAGR of 7–11%, aiming for above-market growth.
Focus areas include advancing hearing innovation, broadening access, commercial excellence, and high-growth markets.
Audiological care business is gaining momentum with improved lead generation and targeted cost initiatives.
Latest events from Sonova
- Sales and profitability accelerated, with new leadership and robust FY25/26 growth expected.SOON
H2 24/258 Jul 2026 - AI-powered hearing aids and operational excellence drive growth and strong market response.SOON
Investor & Analyst Day 20248 Jul 2026 - Solid sales growth and new product launches set the stage for margin expansion in H2.SOON
H1 24/258 Jul 2026 - Strong local-currency growth and margin gains offset by FX and China headwinds.SOON
H1 25/261 Jul 2026 - Strong sales and profit growth, record dividend, but FX and Cochlear Implants headwinds remain.SOON
H2 25/2621 May 2026 - Strategy targets CHF 6bn revenue by 2030/31, driven by innovation, Asia growth, and operational excellence.SOON
Investor update27 Apr 2026